HYPERSPACE VENTURE PTE. LTD.
UEN: 201720248M
HYPERSPACE VENTURE PTE. LTD.(201720248M) is a Singapore business with registered business address at 245 COMPASSVALE ROAD, 7-660, Singapore 540245. They specialise in the area of MANAGEMENT CONSULTANCY SERVICES (GENERAL) and INFORMATION TECHNOLOGY CONSULTANCY (EXCEPT CYBERSECURITY).
| Company Name | HYPERSPACE VENTURE PTE. LTD. |
| Unique Entity Number | 201720248M |
| Entity Type | Local Company |
| Entity Status | Live Company |
| Incorporate Day | 19 July 2017 |
| Address |
245 COMPASSVALE ROAD #7-660 Singapore 540245 |
| Products / Services |
MANAGEMENT CONSULTANCY SERVICES (GENERAL) INFORMATION TECHNOLOGY CONSULTANCY (EXCEPT CYBERSECURITY) |
| Number of Officers | 1 |
| Paid Up Capital | SGD 1000 |
Breaking! Business News
Bombardier Releases its 2019 Activity Report, Highlighting Sustainability Milestones and ObjectivesBombardier Releases its 2019 Activity Report, Highlighting Sustainability Milestones and ObjectivesG...
Read More
International Spirits & Wellness Holdings Enters Joint-Venture Agreement with Official Distributor of Top-Selling Crypto Mining EquipmentInternational Spirits & Wellness Holdings Enters Joint-Venture Agreement with Official Distributor o...
Read More
Zoom Hires Damien Hooper-Campbell as Chief Diversity OfficerZoom Hires Damien Hooper-Campbell as Chief Diversity OfficerTech Industry Veteran to Lead Expansion ...
Read More
Wasabi Builds on Explosive Growth with $30 Million Funding RoundWasabi Builds on Explosive Growth with $30 Million Funding RoundNew investment to drive Wasabi’s g...
Read More
Virtusa to Increase Speed, Reduce Costs of Critical Digital Transformation InitiativesVirtusa to Increase Speed, Reduce Costs of Critical Digital Transformation InitiativesNew Digital Tr...
Read More
Philips Foundation publishes its 2019 Annual Report Philips Foundation publishes its 2019 Annual Report GlobeNewswireMay 28, 2020May 28, 2020 ...
Read More
Atriva Therapeutics to Develop ATR-002 for Treatment of Patients with COVID-19 in Phase II StudyAtriva Therapeutics to Develop ATR-002 for Treatment of Patients with COVID-19 in Phase II StudyGlob...
Read More
Capgemini Press Release // Capgemini and Audi launch new Joint Venture: XL2Capgemini Press Release // Capgemini and Audi launch new Joint Venture: XL2GlobeNewswireMay 28, 2020...
Read More